Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Ga-Young Song, Seok Jin Kim, MD PhD, Sang Eun Yoon, Jin Seok Kim, MD PhD, Ho-Young Yhim, MD PhD, Youngil Koh, MD PhD, Sung Yong Oh, MD PhD, Ho Sup Lee, MD PhD, Ho-Jin Shin, MD PhD, Young Rok Do, MD PhD, Won Sik Lee, MD PhD, Lee Gyeong-Won, Dae Sik Kim, Yong Park, Deok-Hwan Yang, MD PhD

Blood (2019) 134 (Supplement_1): 4002.

https://doi.org/10.1182/blood-2019-126574

Published: 2019

Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Blood (2017) 130 (Supplement 1): 317.

https://doi.org/10.1182/blood.V130.Suppl_1.317.317

Published: 2017

Journal Articles

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

Sukjoong Oh, Ki Hoon Kang, Won-Sik Lee, MD PhD, Hyeoung-Joon Kim, Jee Hyun Kong, Yunsuk Choi, MD, Young Rok Do, MD PhD, Jae-Yong Kwak, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, MD PhD, Yeung-Chul Mun, MD PhD, Young-Woong Won, Sung-Eun Lee, MD, Dong-Wook Kim, MD PhD

Blood (2017) 130 (Supplement 1): 2864.

https://doi.org/10.1182/blood.V130.Suppl_1.2864.2864

Published: 2017

Journal Articles

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

Sung-Eun Lee, MD, Won-Sik Lee, MD PhD, Hyeoung-Joon Kim, Jee Hyun Kong, Yunsuk Choi, MD, Young Rok Do, MD PhD, Jae-Yong Kwak, Sukjoong Oh, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, Yeung-Chul Mun, MD PhD, Young-Woong Won, Dong-Wook Kim, MD PhD

Blood (2017) 130 (Supplement 1): 2873.

https://doi.org/10.1182/blood.V130.Suppl_1.2873.2873

Published: 2017

Journal Articles

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

Blood (2017) 130 (Supplement 1): 2840.

https://doi.org/10.1182/blood.V130.Suppl_1.2840.2840

Published: 2017

Journal Articles

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

Blood (2017) 130 (Supplement 1): 3130.

https://doi.org/10.1182/blood.V130.Suppl_1.3130.3130

Published: 2017

Journal Articles

the Effect of Erythropoiesis-Stimulating Agent on the Management of Chemotherapy-Induced Anemia and Tumor Growth in Diffuse Large B-Cell Lymphoma Patients

Lee Chun Park, MD, Ho Sup Lee, MD, Da Jung Kim, MD, Jee-yeong Jeong, PhD, Jae-Cheol Jo, MD, Won-Sik Lee, MD, Ho-Jin Shin, MD, Sung Yong Oh, Young Rok Do, MD PhD

Blood (2017) 130 (Supplement 1): 5209.

https://doi.org/10.1182/blood.V130.Suppl_1.5209.5209

Published: 2017

Journal Articles

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Seo-Yeon Ahn, Seong Young Kwon, Young Rok Do, MD PhD, Sung-Hoon Jung, MD, Jae-Sook Ahn, Yeo-Kyeoung Kim, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, Su Woong Yoo, Jung-Joon Min, Deok-Hwan Yang, MD PhD

Blood (2017) 130 (Supplement 1): 1546.

https://doi.org/10.1182/blood.V130.Suppl_1.1546.1546

Published: 2017

Journal Articles

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Won-Sik Lee, MD PhD, Hye-Young Song, Hyeoung-Joon Kim, Jee Hyun Kong, Young Rok Do, MD PhD, Jae-Yong Kwak, Sukjoong Oh, Sung-Hyun Kim, MD PhD, Jeong-A Kim, Dae Young Zang, MD PhD, Yeung-Chul Mun, MD PhD, Young-Woong Won, Sung-Eun Lee, MD, Yunsuk Choi, MD, Dong-Wook Kim, MD PhD

Blood (2017) 130 (Supplement 1): 1593.

https://doi.org/10.1182/blood.V130.Suppl_1.1593.1593

Published: 2017

Journal Articles

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Blood (2017) 130 (Supplement 1): 4088.

https://doi.org/10.1182/blood.V130.Suppl_1.4088.4088

Published: 2017

Journal Articles

Whole-Exome Sequencing in Korean Children with Acute Lymphoblastic Leukemia

Ye Jee Shim, MD PhD, Jung-Sook Ha, MD PhD, Young-Rok Do, MD PhD, Heung Sik Kim, MD PhD

Blood (2015) 126 (23): 4994.

https://doi.org/10.1182/blood.V126.23.4994.4994

Published: 2015

Journal Articles

The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma

Ho Sup Lee, Yang Soo Kim, Chang-Ki Min, Je-Jung Lee, MD PhD, Kihyun Kim, MD, Dok Hyun Yoon, MD, Hyeon Seok Eom, Hyewon Lee, MD, Won Sik Lee, MD, Ho-Jin Shin, MD, PhD, Ji Hyun Lee, Yong Park, MD PhD, Jae-Cheol Jo, MD, Young Rok Do, MD, Yeung-Chul Mun

Blood (2014) 124 (21): 3975.

https://doi.org/10.1182/blood.V124.21.3975.3975

Published: 2014

Journal Articles

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

Blood (2014) 124 (21): 3155.

https://doi.org/10.1182/blood.V124.21.3155.3155

Published: 2014

Journal Articles

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 4421.

https://doi.org/10.1182/blood.V124.21.4421.4421

Published: 2014

Journal Articles

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

Cheolsu Kim, Ho Sup Lee, Yang Soo Kim, Chang-Ki Min, Je-Jung Lee, MD PhD, Kihyun Kim, MD, Dok Hyun Yoon, MD, Hyeon Seok Eom, Hyewon Lee, MD, Won Sik Lee, MD, Ho-Jin Shin, MD, PhD, Ji Hyun Lee, Yong Park, MD PhD, Jae-Cheol Jo, MD, Young Rok Do, MD, Yeung-Chul Mun

Blood (2014) 124 (21): 5896.

https://doi.org/10.1182/blood.V124.21.5896.5896

Published: 2014

Journal Articles

Fc γ RIIIa Gene Polymorphisms May Correlate with Response to Frontline R-CHOP Therapy for Diffuse Large B-Cell Lymphoma.

Dong Hwan Kim, MD, PhD, Hee Du Jung, MMS, Sang Kyun Sohn, MD/PhD, Je-Jung Lee, MD/PhD, Deok-Hwan Yang, MD, Yeon Hee Park, MD, Young Rok Do, MD, Ho Jin Shin, MD, Myung Soo Hyun, MD/PhD

Blood (2006) 108 (11): 2457.

https://doi.org/10.1182/blood.V108.11.2457.2457

Published: 2006

Journal Articles

Multidrug Resistance-1 Gene Polymorphism Associated with the Outcomes after Allogeneic HLA-Identical Stem Cell Transplantation.

Dong Hwan Kim, MD, Seok Bong Jeon, MD, Jin Ho Baek, MD, Nan Young Lee, MD, Jong Gwang Kim, MD, Sang Kyun Sohn, MD, Jang Soo Suh, MD, Young Rok Do, MD, Ki Kyung Kwon, MD

Blood (2005) 106 (11): 1757.

https://doi.org/10.1182/blood.V106.11.1757.1757

Published: 2005

Journal Articles

Bcl-2 Mediated Apoptosis Interacts with p53-Dependent Pathway in Progression of Peripheral T-Cell Lymphoma.

Dong Hwan Kim, MD, Jin Tae Jung, MD, Eun Kyung Kwak, MD, Young Rok Do, MD, Jong Gwang Kim, MD, Tae In Park, MD, Sang Kyun Sohn, MD, Ki Wyong Kwon, MD, Hong Suk Song, MD, Kyu Bo Lee, MD

Blood (2004) 104 (11): 4548.

https://doi.org/10.1182/blood.V104.11.4548.4548

Published: 2004

NARROW

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Characterization of ABL Compound Mutation Using Sanger and Subcloning Sequencing in Tyrosine Kinase Inhibitor Resistant Chronic Myeloid Leukemia

The Impact of Early Molecular Response at 3 Months on Long-Term Survival Was Enhanced in the CP CML Patients Treated with Second-Generation Tyrosine Kinase Inhibitors

A Prospective Registry Study of Peg-G-CSF Prophylaxis for Patients with Diffuse Large B-Cell Lymphoma (CISL 1403)

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Nationwide Registry Study of the Korean Multiple Myeloma Working Party (KMMWP)

the Effect of Erythropoiesis-Stimulating Agent on the Management of Chemotherapy-Induced Anemia and Tumor Growth in Diffuse Large B-Cell Lymphoma Patients

Prognostic Significance of Interim 11 c-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Unmet Needs for a Better Treatment in Patients with Peripheral T Cell Lymphoma: Data from a Nationwide, Multi-Center Prospective Registry Study (CISL 1404)

Whole-Exome Sequencing in Korean Children with Acute Lymphoblastic Leukemia

The Clinical Impact of Thalidomide Maintenance on Progression Free Survival and Postrelapse Survival after Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple myeloma

Results from the Korean Imatinib Discontinuation Study (KIDS): Updated Data with 15-Month Median Follow up

Clinical Outcomes of R-CHOP Chemotherapy Alone Compared with R-CHOP Plus Radiotherapy in Patients with Localized, Non-Bulky Diffuse Large B-Cell Lymphoma

The Prognostic Impact of Inflammatory Factors for Survival in Patients with Newly Diagnosed Multiple Myeloma Who Were Treated with Thalidomide Containing Induction Chemotherapy Underwent Autologous Stem Cell Transplantation

Fc γ RIIIa Gene Polymorphisms May Correlate with Response to Frontline R-CHOP Therapy for Diffuse Large B-Cell Lymphoma.

Multidrug Resistance-1 Gene Polymorphism Associated with the Outcomes after Allogeneic HLA-Identical Stem Cell Transplantation.

Bcl-2 Mediated Apoptosis Interacts with p53-Dependent Pathway in Progression of Peripheral T-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only